Data protection Impressum

Financing

Ikerian AG, along with its subsidiary RetinAI, has successfully completed a USD 6.18 million Series A extension financing round to propel the development and commercial rollout of innovative medical technologies.

Ikerian, parent company of RetinAI, secures USD 6.18 million for AI-driven medical advancements

13 May 2024

Testmate Health, a Lausanne-based start-up, has successfully raised USD 6 million to advance the development and commercialization of their at-home rapid test kits for sexually transmitted infections (STIs).

Testmate Health raises USD 6 million to combat STIs with innovative home testing kits

8 May 2024

Bernese medtech machineMD and Oxford-based gaitQ have jointly received a million-dollar research grant from InnovateUK and Innosuisse, aimed at enhancing the monitoring and early detection of Parkinson's disease.

machineMD and gaitQ awarded grant for Parkinson’s research in the UK and Switzerland

7 May 2024

EP Equity Investment (EPEI), a company dedicated to investing in promising European companies, has acquired a 24.99% stake in Nanobacterie to advance the development of innovative treatments for prostate cancer.

Nanobacterie secures strategic investment from EP Equity to advance prostate cancer treatment

6 May 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2024)

30 April 2024

NovaMea, a cleantech start-up from the EPFL, has raised USD 3.2 million to advance the research and development of its green hydrogen production technology.

NovaMea secures USD 3.2 million to boost green hydrogen production

30 April 2024

The FIF has once again highlighted its commitment to propelling tech innovation in Geneva by awarding significant financial support to three promising projects.

Azure Cell Therapies, FireFly Fusion and Antion Biosciences receive FIF support

29 April 2024

Bcomp, a global leader in natural fiber composites, has successfully raised CHF 36 million in a Series C funding round led by EGS Beteiligungen AG.

Bcomp secures CHF 36 million to advance eco-friendly composite materials in mobility

23 April 2024

Isospec Analytics, a Vaud-based start-up specializing in biomolecular analysis, has secured USD 1.9 million in pre-seed funding to advance its revolutionary diagnostic technologies.

Isospec pioneers rapid diagnostic technologies with USD 1.9 million funding

22 April 2024

Vaud-based biopharma Oculis has secured USD 59 million to extend operations into 2026, following a successful listing on NASDAQ Iceland Main Market.

Oculis announces completion of oversubscribed USD 59 million registered direct offering

15 April 2024

1 … 8 9 10 11 12 13 14 15 16 … 32